The Neuroscience:Translate grant program supports research projects at the intersection of biology, engineering and medicine to address practical unmet needs in brain health and the neurosciences.
The program funds cross-disciplinary teams to develop new devices, diagnostic procedures, software, pharmaceutical therapies and other products that can be brought rapidly to market through new startup companies or partnerships with existing companies. Grants of up to $100,000 are awarded annually to approximately six teams. Teams who have previously received Neuroscience:Translate awards may apply for a one-year renewal to continue advancing their technology.
This program was inspired by the successful Stanford Coulter Translational Research program, a partnership between Stanford Bioengineering and the Coulter Foundation managed by the Stanford Byers Center for Biodesign. The Wu Tsai Neurosciences Institute partners with Stanford Biodesign to bring this approach and expertise to bear on the field of neuroscience and brain diseases, with guidance from a Neuroscience:Translate oversight committee comprising scientific and industry leaders in biotechnology development.
Now Accepting Applications
2023 Neuroscience:Translate grant applications are open for submissions viathe Stanford | Seed Funding website.
Application Deadline: October 24, 2022